Sign In
Buy ABBV
$224.93
+7.86 (+3.62%)
At Close: Jun 04, 2026
Buy, Sell or Hold ABBV Stock? Key Tips Ahead of Q1 Earnings
09:35am, Wednesday, 23'rd Apr 2025
Investors will likely focus on the sales performance of AbbVie's blockbuster immunology drugs, Rinvoq and Skyrizi, when it reports Q1 results later this week.
2 High-Yield Dividend Stocks to Buy for Passive Income
08:30am, Wednesday, 23'rd Apr 2025
Passive income is essential in retirement, but building a dependable stream isn't easy. Fortunately, top-tier dividend stocks can do the heavy lifting.
Shareholders that lost money on Cerevel Therapeutics Holdings, Inc. (ABBV) should contact Levi & Korsinsky about pending Class Action - ABBV
07:30am, Wednesday, 23'rd Apr 2025
NEW YORK, NY / ACCESS Newswire / April 23, 2025 / If you suffered a loss on your Cerevel Therapeutics Holdings, Inc. (NYSE:ABBV) investment and want to learn about a potential recovery under the feder
Final Trades: 3M, Abbvie, Salesforce and Intuitive Surgical
01:50pm, Tuesday, 22'nd Apr 2025
The Investment Committee give you their top stocks to watch for the second half.
Eli Lilly, Vertex, AbbVie and More Pharma Stocks to Own as Tariffs Loom
11:13am, Tuesday, 22'nd Apr 2025
Trump's tariff policy is the latest uncertainty to plague the pharmaceutical sector.
Seeking Clues to AbbVie (ABBV) Q1 Earnings? A Peek Into Wall Street Projections for Key Metrics
10:21am, Tuesday, 22'nd Apr 2025
Besides Wall Street's top -and-bottom-line estimates for AbbVie (ABBV), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the qua
Will These 5 Large Drug Maker Stocks Surpass Q1 Earnings Forecast?
10:10am, Tuesday, 22'nd Apr 2025
Let's look at five big pharma companies, GILD, BMY, MRK, ABBV and SNY slated to release their first-quarter 2025 results this week.
NEW YORK , April 22, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Cerevel Therapeutics Holdings, Inc. ("Cerevel Therapeutics Holdings, Inc." or the "Company") (NYSE: ABBV) of a cla
Class Action Filed Against Cerevel Therapeutics Holdings, Inc. (ABBV) Seeking Recovery for Investors – Contact Levi & Korsinsky
01:03pm, Monday, 21'st Apr 2025
NEW YORK, April 21, 2025 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Cerevel Therapeutics Holdings, Inc. ("Cerevel Therapeutics Holdings, Inc." or the "Company") (NYSE: ABBV) of a
LLY, NVO and AMGN Forecast – Pharma Stocks to Open Mixed
09:00am, Monday, 21'st Apr 2025
The three pharma stocks in this analysis all look a bit mixed in the premarket, after seeing some momentum late last week. This is especially true with LLY, as you will see on the charts.
The Gross Law Firm Notifies Cerevel Therapeutics Holdings, Inc. Investors of a Class Action Lawsuit and Upcoming Deadline - ABBV
05:45am, Monday, 21'st Apr 2025
NEW YORK , April 21, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cerevel Therapeutics Holdings, Inc. (NYSE: ABBV). Shareholders who purchased shares of ABBV
Is AbbVie Stock a Buy?
08:15am, Sunday, 20'th Apr 2025
It's been a stomach-churning past few months for investors in pharmaceutical giant AbbVie (ABBV 0.62%). A potential blockbuster drug that AbbVie spent roughly $9 billion to acquire the rights to faile
AbbVie (ABBV) Earnings Expected to Grow: What to Know Ahead of Next Week's Release
11:05am, Friday, 18'th Apr 2025
AbbVie (ABBV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
One Sector Paying Big Dividends Is Off to the Best Start in 25 Years Despite Tariffs
08:47am, Friday, 18'th Apr 2025
Investors love dividend stocks, especially the high-yield variety, because they offer a significant income stream and have massive total return potential.
NEW YORK , April 18, 2025 /PRNewswire/ -- Levi & Korsinsky, LLP notifies investors in Cerevel Therapeutics Holdings, Inc. ("Cerevel Therapeutics Holdings, Inc." or the "Company") (NYSE: ABBV) of a cla
